E Vigneault
Overview
Explore the profile of E Vigneault including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reynaud T, Ben Aicha I, Carignan D, Pelchat C, Fiset C, Foster W, et al.
Cancer Radiother
. 2023 Apr;
27(3):214-218.
PMID: 37080858
Purpose: The aim of this retrospective study is to assess the risk of infection after transrectal ultrasound-guided fiducial marker insertion for image-guided radiotherapy of prostate cancer. Material And Methods: Between...
2.
Beaudry M, Carignan D, Foster W, Lavallee M, Aubin S, Lacroix F, et al.
Clin Transl Radiat Oncol
. 2023 Mar;
40:100593.
PMID: 36875870
Purpose/objectives: To analyze the long term efficacy and safety of an ultra-hypofractionated (UHF) radiation therapy prostate treatment regimen with HDR brachytherapy boost (BB) and compare it to moderate-hypofractionated regimens (MHF)....
3.
Belliveau C, Barkati M, Delouya G, Taussky D, Beauchemin M, Lambert C, et al.
Radiat Oncol
. 2022 Dec;
17(1):203.
PMID: 36494834
Background: For patients with a higher burden of localized prostate cancer, radiation dose escalation with brachytherapy boosts have improved cancer control outcomes at the cost of urinary toxicity. We hypothesize...
4.
Loewen S, Halperin R, Perry G, McKenzie M, Vigneault E, Stuckless T, et al.
Curr Oncol
. 2019 Sep;
26(4):e510-e514.
PMID: 31548819
Introduction: Radiation oncology (ro) is one of several specialties identified by the Royal College of Physicians and Surgeons of Canada with employment difficulties for graduating trainees. The purpose of the...
5.
Vigneault E, Morton G, Parulekar W, Niazi T, Springer C, Barkati M, et al.
Clin Oncol (R Coll Radiol)
. 2018 Jun;
30(9):527-533.
PMID: 29903505
Aims: We conducted a multicentre feasibility study to assess the ability to randomise patients between image-guided radiotherapy (IGRT) and IGRT + high dose rate (HDR) brachytherapy boost and to adhere...
6.
Loblaw A, Pickles T, Crook J, Martin A, Vigneault E, Souhami L, et al.
Clin Oncol (R Coll Radiol)
. 2016 Oct;
29(3):161-170.
PMID: 27780694
Aims: To compare biochemical failure-free survival (BFFS) and overall survival for prostate cancer treated with stereotactic ablative radiotherapy (SABR), low dose rate (LDR) brachytherapy or external beam radiotherapy (EBRT) using...
7.
Zimmermann M, Taussky D, Menkarios C, Vigneault E, Beauchemin M, Bahary J, et al.
Clin Oncol (R Coll Radiol)
. 2016 Jan;
28(6):386-92.
PMID: 26782838
Aims: To report the long-term toxicities and sexual quality of life of a once-weekly hypofractionated radiation therapy schedule for low-risk prostate cancer. Materials And Methods: A multi-institutional phase II trial...
8.
Zebentout O, Apardian R, Beaulieu L, Harel F, Martin A, Vigneault E
Cancer Radiother
. 2010 Apr;
14(3):183-8.
PMID: 20418145
Purpose: To describe the biochemical failure-free survival (BFFS), GU toxicity and erectile dysfunction in intermediate risk prostate cancer treated with iodine 125 monotherapy (I125). Patients And Methods: Between October 1994...
9.
Foster W, Beaulieu L, Harel F, Martin A, Vigneault E
Cancer Radiother
. 2007 Nov;
11(8):452-60.
PMID: 17997118
Purpose: To evaluate the impact of adaptative image-guided brachytherapy on therapeutic outcome and toxicity in prostate cancer. Materials And Methods: The 1,110 first patients treated at the CHUQ-l'Hôtel-Dieu de Québec...
10.
Aubin S, Beaulieu L, Pouliot S, Pouliot J, Roy R, Girouard L, et al.
Med Phys
. 2003 Aug;
30(7):1825-32.
PMID: 12906201
An algorithm for the daily localization of the prostate using implanted markers and a standard video-based electronic portal imaging device (V-EPID) has been tested. Prior to planning, three gold markers...